Medical News |
- Metabolic syndrome prevalent in Indian schizophrenia patients
- Short psychoeducational program may benefit BD patients
- Metformin benefits in diabetes management ‘still unclear’
- Two drinks a day linked to reduced mortality after first heart attack
- Black hypertensive patients at increased sudden death risk
- Metformin benefits in diabetes management ‘still unclear’
- Women risk developing the metabolic syndrome through lack of exercise
- Contrast agent impact on thrombolysis uncertain
- Semuloparin trumps enoxaparin after hip replacement
| Metabolic syndrome prevalent in Indian schizophrenia patients Posted: 16 Apr 2012 05:00 PM PDT Results from an Indian study suggest that nearly half of patients with schizophrenia meet criteria for the metabolic syndrome, with increased waist circumference being the most common component. |
| Short psychoeducational program may benefit BD patients Posted: 16 Apr 2012 05:00 PM PDT A short, mobile phone-based psychoeducational program may improve knowledge of mood management strategies in patients with bipolar disorder, study results suggest. |
| Metformin benefits in diabetes management ‘still unclear’ Posted: 15 Apr 2012 05:00 PM PDT The efficacy of metformin in preventing death or cardiovascular events has not been proven by current studies, even though the drug is considered the first-line treatment for Type 2 diabetes, show findings from a meta-analysis. |
| Two drinks a day linked to reduced mortality after first heart attack Posted: 15 Apr 2012 05:00 PM PDT Long-term moderate alcohol consumption is inversely linked with all-cause and cardiovascular mortality in men who have survived a myocardial infarction, a study suggests. |
| Black hypertensive patients at increased sudden death risk Posted: 15 Apr 2012 05:00 PM PDT Black hypertensive patients are at a significantly increased risk for sudden cardiac death, findings from the LIFE study show. |
| Metformin benefits in diabetes management ‘still unclear’ Posted: 15 Apr 2012 05:00 PM PDT The efficacy of metformin in preventing death or cardiovascular events has not been proven by current studies, even though the drug is considered the first-line treatment for Type 2 diabetes, show findings from a meta-analysis. |
| Women risk developing the metabolic syndrome through lack of exercise Posted: 15 Apr 2012 05:00 PM PDT Women are less likely than men to get at least 30 minutes of exercise per day, resulting in greater odds for developing the metabolic syndrome, show results of a US study. |
| Contrast agent impact on thrombolysis uncertain Posted: 15 Apr 2012 05:00 PM PDT Use of X-ray contrast agents in patients with acute stroke could have a small impact on the efficacy of intravenous thrombolysis, say researchers from the Calgary Stroke Program. |
| Semuloparin trumps enoxaparin after hip replacement Posted: 15 Apr 2012 05:00 PM PDT Semuloparin is superior to enoxaparin for venous thromboembolism prevention after hip replacement surgery, but not after knee replacement or hip fracture surgery, show results of three phase III trials. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment